Mylan NV (NASDAQ:MYL) - Share price - Overview

Stock Report

Mylan NV MYL

Last Price
$39.33

Day Change
-0.30|-0.76%

As of 24/05/2018
19:06:15 EDT | USD
Minimum 15 Minutes Delay.

Last Close39.63
Day Range38.94 - 39.89
Mkt Cap20.27Bil
52-Wk Range29.39 - 47.82
Yield %-
ISINNL0011031208
Volume3,329,930
P/E29.13
P/S1.76
P/CF9.36

Share Price

Financials
201520162017
More ...
Income Statement
Revenue9,429.3011,076.9011,907.70
Operating Income1,363.501,374.101,424.00
Net Income847.60480.00696.00
Basic EPS1.800.941.30
Avg. Diluted Shares Outstanding497521537
Balance Sheet
Current Assets6,472.707,522.507,213.30
Non Current Assets15,795.0027,203.7028,593.00
Total Assets22,267.7034,726.2035,806.30
Current Liabilities4,122.205,040.706,385.30
Total Liabilities---
Total Equity9,764.4011,116.2013,307.60
Cash Flow
Operating Cash Flow2,008.502,047.202,064.80
Capital Expenditure-871.70-750.60-896.20
Free Cash Flow1,136.801,296.601,168.60

In millions, except "Basic EPS". Currency is USD.

Company Profile

Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

33,417
Key Stats
More ...
Price/Earning TTM29.36
Price/Book1.55
Price/Sales TTM1.79
Rev Growth (3 year avg)15.54
EPS Growth (3 year avg)-
Operating Margin % TTM11.96
Net Margin % TTM5.84
ROE TTM5.70
Debt/Equity0.97
Dividends
PreviousLatest
More ...
Declared Date15/03/0718/06/07
Ex-Div28/03/0727/06/07
Paid16/04/0716/07/07
Amnt0.060.06
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.